BAX
47
2
HSY
41
3
MDLZ
55
2
MAT
58
2
GM
60
11
PAYX
41
-4
BMY
40
2
O
39
2
NRG
72
-5
MRO
56
10
IP
51
3
EL
50
7
EIX
50
2
AES
35
2
BWA
41
5
PH
69
-2
AEP
34
5
PSX
34
-6
IFF
45
3
PYPL
45
-2
BAX
47
2
HSY
41
3
MDLZ
55
2
MAT
58
2
GM
60
11
PAYX
41
-4
BMY
40
2
O
39
2
NRG
72
-5
MRO
56
10
IP
51
3
EL
50
7
EIX
50
2
AES
35
2
BWA
41
5
PH
69
-2
AEP
34
5
PSX
34
-6
IFF
45
3
PYPL
45
-2
Financhill
Back

Novavax Quote, Financials, Valuation and Earnings

NOW is the time to get in on this trillion-dollar megatrend

Get it here.
Sell
24

NVAX
Novavax

Last Price:
3.99
Seasonality Move:
27.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!

Act now for your path to extra income!

Novavax Price Quote

$3.99
+0.02 (+2.44%)
(Updated: April 20, 2024 at 4:21 AM ET)

Novavax Key Stats

Sell
24
Novavax (NVAX) is a Sell
Day range:
$3.86 - $4.02
52-week range:
$3.53 - $11.36
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.60
P/B ratio:
0%
Volume:
2.8M
Avg. volume:
4.4M
1-year change:
-55.69%
Market cap:
$555.6M
Revenue:
$556.4M
EPS:
$-5.56

How Much Does Novavax Make?

  • How Much Are Novavax's Sales Annually?
    NVAX Revenues are $556.4M
  • How Much Profit Does Novavax's Make A Year?
    NVAX net income is -$545.1M

Is Novavax Growing As A Company?

  • What Is Novavax's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.12%
  • What Is Novavax's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Novavax Stock Price Performance

  • Did Novavax Stock Go Up Last Month?
    Novavax share price went down by -19.64% last month
  • Did NVAX's Share Price Rise Over The Last Year?
    NVAX share price fell by -55.69% over the past 1 year

What Is Novavax 52-Week High & Low?

  • What Is Novavax’s 52-Week High Share Price?
    Novavax has traded as high as $11.36 over the past 52 weeks
  • What Is Novavax’s 52-Week Low Share Price?
    Novavax has traded as low as $3.53 over the past 52 weeks

Novavax Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Novavax?

  • How Much Debt Does Novavax Have?
    Total long term debt quarterly is $168M
  • How Much Cash Does Novavax Have?
    Cash and short term investments quarterly total is $568.5M
  • What Is Novavax’s Book Value Per Share?
    Book value per share is -5.14

Is Novavax Cash Flow Positive?

  • What Is NVAX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$714M
  • What Is Novavax’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $4.5M
  • What Is Novavax’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$58.8M

Novavax Return On Invested Capital

Data Unavailable

Novavax Earnings Date & Stock Price

  • What Is Novavax's Stock Price Today?
    A single share of NVAX can be purchased today for 3.97
  • What Is Novavax’s Stock Symbol?
    Novavax trades on the nasdaq under the ticker symbol: NVAX
  • When Is Novavax’s Next Earnings Date?
    The next quarterly earnings date for Novavax is scheduled on May 9, 2024
  • When Is NVAX's next ex-dividend date?
    Novavax's next ex-dividend date is April 20, 2024
  • How To Buy Novavax Stock?
    You can buy Novavax shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Novavax Competitors

  • Who Are Novavax's Competitors?
    Below is a list of companies who compete with Novavax or are related in some way:
    • Agilent Technologies Inc (A)
    • Lexicon Pharmaceuticals Inc (LXRX)
    • Moderna Inc (MRNA)
    • Pfizer Inc (PFE)
    • Vaxart Inc (VXRT)

Novavax Dividend Yield

Data Unavailable

Novavax Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -313.4%
Revenue: -11.96% -9.51%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 15.40
Upside from Last Price: 287.91%

Major Shareholders

  • How many NVAX shares are owned by institutional investors?
    126.1M NVAX shares are owned by institutional investors
  • How many NVAX shares are owned by insiders?
    2M NVAX shares are owned by insiders